Hello - New Member

New members should feel free to introduce themselves here
Post Reply
User avatar
Chilax
Getting to Know You...
Posts: 24
Joined: Sat Dec 04, 2010 3:00 pm
Location: New Jersey (USA)
Contact:

Hello - New Member

Post by Chilax »

Hi,

I was diagnosed in October after four weeks of diplopia. I have several lesions in the brain and one in the cord. My EDSS is 1.5. My symptoms include poor balance, weak left leg / arm, and memory.

I was on IV steriods last week and oral for one more week. After discussing the DMD treatments with my MS neuro we decided on Gilenya over Tysabri. I read the Tysabri & Gilenya efficacy / safety Trials and I concluded the benefits of Gilenya outweigh the risks.

Do you use Gilenya? What has your experience been thus far?

Thanks in advance.

Al
User avatar
ppicklee
Family Member
Posts: 82
Joined: Sun Jan 10, 2010 3:00 pm
Contact:

:-)

Post by ppicklee »

Hi there and welcome!
I'm sorry but I'm not able to tell you anything about those DMD's as I have not used either one.
Perhaps if you go to the Drug Pipeline Thread you can find out more information there.
Anyways... WELCOME! :-)
p
User avatar
Chilax
Getting to Know You...
Posts: 24
Joined: Sat Dec 04, 2010 3:00 pm
Location: New Jersey (USA)
Contact:

Post by Chilax »

Thanks for the reply. Hopefully I will hear from others that are / will be using Gilenya. If the moderators set-up a Gilenya folder under the "treatments" section I will gladly share with our community my experience with Gilenya (perhaps sort of like a weekly log). I need to undergo several testa (EKG, blood work, opthomalgic exam for macular edema - passed this one) prior to treatment.

I have found the TIMS community to be very knowledgeable, in my humble opinion. The website is simply awesome & I hop to be a more active member that can help others with whatever information I can share from my experiences with all facets of MS.

Lastly, I am in a CCSVI clinical trial at Albany (Vascular Group - Dr. Mehta).

Thanks again for your reply.

Al
Post Reply

Return to “Introductions”